Susceptibility of N-Acetyltransferase 2 Slow Acetylators to Antituberculosis Drug-Induced Liver Injury: A Meta-Analysis

References

• Huang YS . Recent progress in genetic variation and risk of antituberculosis drug-induced liver injury . J. Chin. Med. Assoc.77 ( 4 ), 169 – 173 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Tostmann A , BoereeMJ , AarnoutseRE , De LangeWC , Van Der VenAJ , DekhuijzenR . Antituberculosis drug-induced hepatotoxicity: concise up-to-date review . J. Gastroenterol. Hepatol.23 ( 2 ), 192 – 202 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Lin HJ , HanCY , LinBK , HardyS . Slow acetylator mutations in the human polymorphic n-acetyltransferase gene in 786 asians, blacks, hispanics, and whites: application to metabolic epidemiology . Am. J. Hum. Genet.52 ( 4 ), 827 – 834 ( 1993 ).
   PubMed Web of Science ®Google Scholar
• Santos NP , Callegari-JacquesSM , Ribeiro Dos SantosAKet al. N-acetyl transferase 2 and cytochrome p450 2e1 genes and isoniazid-induced hepatotoxicity in brazilian patients . Int. J. Tuberc. Lung Dis.17 ( 4 ), 499 – 504 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Little J , BradleyL , BrayMSet al. Reporting, appraising, and integrating data on genotype prevalence and gene-disease associations . Am. J. Epidemiol.156 ( 4 ), 300 – 310 ( 2002 ).
   PubMed Web of Science ®Google Scholar
• Begg CB , MazumdarM . Operating characteristics of a rank correlation test for publication bias . Biometrics50 ( 4 ), 1088 – 1101 ( 1994 ).
   PubMed Web of Science ®Google Scholar
• Egger M , Davey SmithG , SchneiderM , MinderC . Bias in meta-analysis detected by a simple, graphical test . BMJ315 ( 7109 ), 629 – 634 ( 1997 ).
   PubMed Web of Science ®Google Scholar
• Huang YS , ChernHD , SuWJet al. Cytochrome p450 2e1 genotype and the susceptibility to antituberculosis drug-induced hepatitis . Hepatology37 ( 4 ), 924 – 930 ( 2003 ).
   PubMed Web of Science ®Google Scholar
• Sistanizad M , AziziE , KhaliliH , HajiabdolbaghiM , GholamiK , MahjubR . Antituberculosis drug-induced hepatotoxicity in Iranian tuberculosis patients: role of isoniazid metabolic polymorphism . Iran. J. Pharm. Res.10 ( 3 ), 633 – 639 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• An HR , WuXQ , WangZY , LiangY , ZhangJX . The associations of polymorphism of N-acetyltransferase 2 gene is associated with antituberculosis drug-induced hepatotoxicity in tuberculosis patients . Zhonghua Yu Fang Yi Xue Za Zhi45 ( 1 ), 36 – 40 ( 2011 ).
   PubMedGoogle Scholar
• Rana SV , OlaRP , SharmaSKet al. Comparison between acetylator phenotype and genotype polymorphism of n-acetyltransferase-2 in tuberculosis patients . Hepatol. Int.6 ( 1 ), 397 – 402 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• An HR , WuXQ , WangZY , ZhangJX , LiangY . Nat2 and cyp2e1 polymorphisms associated with antituberculosis drug-induced hepatotoxicity in Chinese patients . Clin. Exp. Pharmacol. Physiol.39 ( 6 ), 535 – 543 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Khalili H , FouladdelS , SistanizadM , HajiabdolbaghiM , AziziE . Association of n-acetyltransferase-2 genotypes and antituberculosis induced liver injury; first case-controlled study from iran . Curr. Drug Saf.6 ( 1 ), 17 – 22 ( 2011 ).
   PubMedGoogle Scholar
• Huang YS , ChernHD , SuWJet al. Polymorphism of the N-acetyltransferase 2 gene as a susceptibility risk factor for antituberculosis drug-induced hepatitis . Hepatology35 ( 4 ), 883 – 889 ( 2002 ).
   PubMed Web of Science ®Google Scholar
• Rana SV , SharmaSK , OlaRPet al. N-acetyltransferase 2, cytochrome p4502e1 and glutathione s-transferase genotypes in antitubercular treatment-induced hepatotoxicity in North Indians . J. Clin. Pharm. Ther.39 ( 1 ), 91 – 96 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Zaverucha-Do-Valle C , MonteiroSP , El-JaickKBet al. The role of cigarette smoking and liver enzymes polymorphisms in antituberculosis drug-induced hepatotoxicity in Brazilian patients . Tuberculosis (Edinb.)94 ( 3 ), 299 – 305 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Yimer G , UedaN , HabtewoldAet al. Pharmacogenetic & pharmacokinetic biomarker for efavirenz based arv and rifampicin based anti-tb drug induced liver injury in TB-HIV infected patients . PLoS ONE6 ( 12 ), e27810 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Possuelo LG , CastelanJA , De BritoTCet al. Association of slow N-acetyltransferase 2 profile and anti-tb drug-induced hepatotoxicity in patients from Southern Brazil . Eur. J. Clin. Pharmacol.64 ( 7 ), 673 – 681 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Sotsuka T , SasakiY , HiraiS , YamagishiF , UenoK . Association of isoniazid-metabolizing enzyme genotypes and isoniazid-induced hepatotoxicity in tuberculosis patients . In Vivo25 ( 5 ), 803 – 812 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Roy B , ChowdhuryA , KunduSet al. Increased risk of antituberculosis drug-induced hepatotoxicity in individuals with glutathione s-transferase m1 ‘null’ mutation . J. Gastroenterol. Hepatol.16 ( 9 ), 1033 – 1037 ( 2001 ).
   PubMed Web of Science ®Google Scholar
• Singh M , GuptaVH , AmarapurkarDNet al. Association of genetic variants with antituberculosis drug induced hepatotoxicity: a high resolution melting analysis . Infect. Genet. Evol.23 , 42 – 48 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Kim SH , BahnJW , KimYKet al. Genetic polymorphisms of drug-metabolizing enzymes and anti-tb drug-induced hepatitis . Pharmacogenomics10 ( 11 ), 1767 – 1779 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Roy B , GhoshSK , SutradharD , SikdarN , MazumderS , BarmanS . Predisposition of antituberculosis drug induced hepatotoxicity by cytochrome p450 2e1 genotype and haplotype in pediatric patients . J. Gastroenterol. Hepatol.21 ( 4 ), 784 – 786 ( 2006 ).
   PubMed Web of Science ®Google Scholar
• Ho HT , WangTH , HsiongCHet al. The nat2 tag snp rs1495741 correlates with the susceptibility of antituberculosis drug-induced hepatotoxicity . Pharmacogenet. Genomics23 ( 4 ), 200 – 207 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Vuilleumier N , RossierMF , ChiappeAet al. Cyp2e1 genotype and isoniazid-induced hepatotoxicity in patients treated for latent tuberculosis . Eur. J. Clin. Pharmacol.62 ( 6 ), 423 – 429 ( 2006 ).
   PubMedGoogle Scholar
• Cho HJ , KohWJ , RyuYJet al. Genetic polymorphisms of nat2 and cyp2e1 associated with antituberculosis drug-induced hepatotoxicity in korean patients with pulmonary tuberculosis . Tuberculosis (Edinb.)87 ( 6 ), 551 – 556 ( 2007 ).
   PubMed Web of Science ®Google Scholar
• Bozok Cetintas V , ErerOF , KosovaBet al. Determining the relation between n-acetyltransferase-2 acetylator phenotype and antituberculosis drug induced hepatitis by molecular biologic tests . Tuberk Toraks56 ( 1 ), 81 – 86 ( 2008 ).
   PubMedGoogle Scholar
• Yamada S , TangM , RichardsonKet al. Genetic variations of nat2 and cyp2e1 and isoniazid hepatotoxicity in a diverse population . Pharmacogenomics10 ( 9 ), 1433 – 1445 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Lee SW , ChungLS , HuangHH , ChuangTY , LiouYH , WuLS . Nat2 and cyp2e1 polymorphisms and susceptibility to first-line antituberculosis drug-induced hepatitis . Int. J. Tuberc. Lung Dis.14 ( 5 ), 622 – 626 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Leiro-Fernandez V , ValverdeD , Vazquez-GallardoRet al. N-acetyltransferase 2 polymorphisms and risk of antituberculosis drug-induced hepatotoxicity in Caucasians . Int. J. Tuberc. Lung Dis.15 ( 10 ), 1403 – 1408 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Forestiero FJ , CeconL , HirataMHet al. Relationship of nat2, cyp2e1 and gstm1/gstt1 polymorphisms with mild elevation of liver enzymes in brazilian individuals under antituberculosis drug therapy . Clin. Chim. Acta415 , 215 – 219 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Chamorro JG , CastagninoJP , MusellaRMet al. Sex, ethnicity, and slow acetylator profile are the major causes of hepatotoxicity induced by antituberculosis drugs . J. Gastroenterol. Hepatol.28 ( 2 ), 323 – 328 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Gupta VH , AmarapurkarDN , SinghMet al. Association of N-acetyltransferase 2 and cytochrome p450 2e1 gene polymorphisms with antituberculosis drug-induced hepatotoxicity in western india . J. Gastroenterol. Hepatol.28 ( 8 ), 1368 – 1374 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Ohno M , YamaguchiI , YamamotoIet al. Slow N-acetyltransferase 2 genotype affects the incidence of isoniazid and rifampicin-induced hepatotoxicity . Int. J. Tuberc. Lung Dis.4 ( 3 ), 256 – 261 ( 2000 ).
   PubMed Web of Science ®Google Scholar
• Higuchi N , TaharaN , YanagiharaKet al. Nat2 6a, a haplotype of the N-acetyltransferase 2 gene, is an important biomarker for risk of antituberculosis drug-induced hepatotoxicity in Japanese patients with tuberculosis . World J. Gastroenterol.13 ( 45 ), 6003 – 6008 ( 2007 ).
   PubMed Web of Science ®Google Scholar
• Teixeira RL , MoratoRG , CabelloPHet al. Genetic polymorphisms of nat2, cyp2e1 and gst enzymes and the occurrence of antituberculosis drug-induced hepatitis in Brazilian TB patients . Mem. Inst. Oswaldo Cruz.106 ( 6 ), 716 – 724 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Lv X , TangS , XiaYet al. Nat2 genetic polymorphisms and antituberculosis drug-induced hepatotoxicity in Chinese community population . Ann. Hepatol.11 ( 5 ), 700 – 707 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Xiang Y , MaL , WuWet al. The incidence of liver injury in uyghur patients treated for tb in xinjiang uyghur autonomous region, China, and its association with hepatic enzyme polymorphisms nat2, cyp2e1, gstm1 and gstt1 . PLoS ONE9 ( 1 ), e85905 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Shimizu Y , DobashiK , MitaYet al. DNA microarray genotyping of N-acetyltransferase 2 polymorphism using carbodiimide as the linker for assessment of isoniazid hepatotoxicity . Tuberculosis (Edinb.)86 ( 5 ), 374 – 381 ( 2006 ).
   PubMed Web of Science ®Google Scholar
• Bose PD , SarmaMP , MedhiS , DasBC , HusainSA , KarP . Role of polymorphic n-acetyl transferase2 and cytochrome p4502e1 gene in antituberculosis treatment-induced hepatitis . J. Gastroenterol. Hepatol.26 ( 2 ), 312 – 318 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Wu YM , LuoZY , ZhangHM , PengJF , LiuSY , WangM . The association between nat2 polymorphism and antituberculosis drug-induced hepatitis . Zhonghua Gan Zang Bing Za Zhi18 ( 6 ), 467 – 469 ( 2010 ).
   PubMedGoogle Scholar
• Guo M , SunYH , LiSMet al. The relationship between polymorphisms of N-acetyltransferase 2 genes and antituberculosis drug induced hepatic-injury . Chin. J. Infect. Dis.28 ( 2 ), 99 – 102 ( 2010 ).
   Google Scholar
• Huang DS , ZouYH , HeG , LvJC , WangYN . Association between polymorphism of N-acetyltransferase 2 gene and development of antituberculosis drug-induced liver injury . Chin. J. Biomed. Eng.17 ( 5 ), 444 – 447 ( 2011 ).
   Google Scholar
• Ben Mahmoud L , GhozziH , KamounAet al. Polymorphism of the N-acetyltransferase 2 gene as a susceptibility risk factor for antituberculosis drug-induced hepatotoxicity in tunisian patients with tuberculosis . Pathol. Biol. (Paris)60 ( 5 ), 324 – 330 ( 2012 ).
   PubMedGoogle Scholar
• Singla N , GuptaD , BirbianN , SinghJ . Association of nat2, gst and cyp2e1 polymorphisms and antituberculosis drug-induced hepatotoxicity . Tuberculosis (Edinb.)94 ( 3 ), 293 – 298 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Saukkonen JJ , CohnDL , JasmerRMet al. An official ats statement: hepatotoxicity of antituberculosis therapy . Am. J. Respir. Crit. Care Med.174 ( 8 ), 935 – 952 ( 2006 ).
   PubMed Web of Science ®Google Scholar
• Matsumoto T , OhnoM , AzumaJ . Future of pharmacogenetics-based therapy for tuberculosis . Pharmacogenomics15 ( 5 ), 601 – 607 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Yew WW , LeungCC . Antituberculosis drugs and hepatotoxicity . Respirology11 ( 6 ), 699 – 707 ( 2006 ).
   PubMed Web of Science ®Google Scholar
• Yamamoto T , SuouT , HirayamaC . Elevated serum aminotransferase induced by isoniazid in relation to isoniazid acetylator phenotype . Hepatology6 ( 2 ), 295 – 298 ( 1986 ).
   PubMed Web of Science ®Google Scholar
• Mitchell JR , ThorgeirssonUP , BlackMet al. Increased incidence of isoniazid hepatitis in rapid acetylators: possible relation to hydranize metabolites . Clin Pharmacol. Ther.18 ( 1 ), 70 – 79 ( 1975 ).
   PubMed Web of Science ®Google Scholar
• Mitchell JR , ZimmermanHJ , IshakKGet al. Isoniazid liver injury: clinical spectrum, pathology, and probable pathogenesis . Ann. Intern. Med.84 ( 2 ), 181 – 192 ( 1976 ).
   PubMed Web of Science ®Google Scholar
• Cai Y , YiJ , ZhouCet al. Pharmacogenetic study of drug-metabolising enzyme polymorphisms on the risk of antituberculosis drug-induced liver injury: a meta-analysis . PLoS ONE7 ( 10 ), e47769 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Wang PY , XieSY , HaoQet al. NAT2 polymorphisms and susceptibility to antituberculosis drug-induced liver injury: a meta-analysis . Int. J. Tuberc. Lung Dis.16 ( 5 ), 589 – 595 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Sun F , ChenY , XiangYet al. Drug-metabolising enzyme polymorphisms and predisposition to antituberculosis drug-induced liver injury: a meta-analysis . Int. J. Tuberc. Lung Dis.12 ( 9 ), 994 – 1002 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Du H , ChenX , FangYet al. Slow N-acetyltransferase 2 genotype contributes to antituberculosis drug-induced hepatotoxicity: a meta-analysis . Mol. Biol. Rep.40 ( 5 ), 3591 – 3596 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Azuma J , OhnoM , KubotaRet al. Nat2 genotype guided regimen reduces isoniazid-induced liver injury and early treatment failure in the 6-month four-drug standard treatment of tuberculosis: a randomized controlled trial for pharmacogenetics-based therapy . Eur. J. Clin. Pharmacol.69 ( 5 ), 1091 – 1101 ( 2013 ).
   PubMed Web of Science ®Google Scholar